251 related articles for article (PubMed ID: 19654558)
1. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
2. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine liver metastases.
Reddy SK; Clary BM
Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of neuroendocrine cancers.
Modlin IM; Kidd M; Drozdov I; Siddique ZL; Gustafsson BI
Expert Opin Pharmacother; 2008 Oct; 9(15):2617-26. PubMed ID: 18803449
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
6. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
7. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options for gastrointestinal carcinoids.
Modlin IM; Latich I; Kidd M; Zikusoka M; Eick G
Clin Gastroenterol Hepatol; 2006 May; 4(5):526-47. PubMed ID: 16630755
[TBL] [Abstract][Full Text] [Related]
9. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
10. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
Nakakura EK; Venook AP; Bergsland EK
Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with hepatic metastases from neuroendocrine tumors.
Clift AK; Frilling A
Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
[TBL] [Abstract][Full Text] [Related]
13. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Ruszniewski P; O'Toole D
Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
[TBL] [Abstract][Full Text] [Related]
14. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
Nazario J; Gupta S
Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
[TBL] [Abstract][Full Text] [Related]
15. Liver-directed therapies for metastatic neuroendocrine tumors.
Garrot C; Stuart K
Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
[TBL] [Abstract][Full Text] [Related]
16. Thermal ablative therapies for secondary hepatic malignancies.
Mayo SC; Pawlik TM
Cancer J; 2010; 16(2):111-7. PubMed ID: 20404607
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
18. Current medical treatment of pancreatic neuroendocrine tumors.
Yalcin S; Oyan B; Bayraktar Y
Hepatogastroenterology; 2007; 54(73):278-84. PubMed ID: 17419276
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic alternatives in metastatic neuroendocrine tumors.
Miller CA; Ellison EC
Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
[TBL] [Abstract][Full Text] [Related]
20. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
Kvols LK; Turaga KK; Strosberg J; Choi J
J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
